EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases



Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases



Arthritis and Rheumatism 63(8): 2540-2542




(PDF emailed within 0-6 h: $19.90)

Accession: 056679106

Download citation: RISBibTeXText

PMID: 21547891

DOI: 10.1002/art.30431



Related references

Mesenchymal stromal cells as an adjuvant treatment for severe late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Acta Haematologica 133(1): 72-77, 2015

Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation. European Journal of Haematology 89(3): 220-227, 2012

Co-transplantation of haploidentical hematopoietic stem cell and allogeneic bone-marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections. European Journal of Haematology: -, 2018

Treatment of Severe Systemic Sclerosis with Allogeneic Marrow Transplantation. Blood 100(11): Abstract No 5418, November 16, 2002

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis. Arthritis Research & Therapy 19(1): 165-165, 2017

Hemodialysis and renal transplantation in progressive systemic sclerosis: report of 2 cases. Clinical Nephrology 12(4): 178-185, 1979

AB0505Case report of allogeneic unrelated-donor mesenchymal stem cells (msc) infusion in systemic sclerosis (ssc). Annals of the Rheumatic Diseases 72(Suppl 3): A943.1-A943, 2013

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Multiple Sclerosis 15(5): 644-646, 2009

Autologous peripheral blood selected CD34+ cell transplantation for the treatment of severe progressive systemic sclerosis. Blood 88(10 SUPPL 1 PART 1-2): 284B, 1996

A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol. Bmj Open 8(8): E020479-E020479, 2018

EBV related post-transplantation lymphoproliferative diseases in patients with severe aplastic anemia after allogeneic hematopoietic stem cell transplantation: five cases report and literatures review. Zhonghua Xue Ye Xue Za Zhi 37(11): 998-1000, 2016

Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases. Acta Medica Scandinavica 193(5): 477-480, 1973

Treatment of progressive systemic sclerosis with penicillamine preliminary report of 2 cases. Acta Medica Scandinavica 193(5): 477-480, 1973

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet. Respiratory Medicine: -, 2018

Co-Transplantation of Ex-Vivo Culture-Expanded Human Mesenchymal Stem Cells and Allogeneic Hematopoietic Stem Cell Transplantation - Report of 12 Cases. Blood 100(11): Abstract No 4234, November 16, 2002